Joint Study Finds Hospitals Using Nuance Clinical Documentation Improvement Score Higher on Quantros’ CareChex® Rankings f...
June 27 2016 - 9:41AM
Business Wire
Download White Paper and findings: Measuring the Real
Impact of Clinical Documentation Improvement on Value-based
Reimbursement
Quantros, Inc., the healthcare industry’s leading provider of
enterprise safety risk management, quality management and
performance analytics solutions, and Nuance Communications, Inc.
(Nasdaq: NUAN), jointly announced the results of a study that
showed significant quality improvement for hospitals implementing
Nuance’s clinical documentation improvement (CDI) solutions. Using
Quantros’ CareChex® hospital quality ratings methodology, the study
specifically focused on measures of Observed to Expected Mortality,
as these are most aligned with proper identification of a patient’s
principal diagnosis and patient severity changes reflected in
clinical documentation.
This Smart News Release features multimedia.
View the full release here:
http://www.businesswire.com/news/home/20160627005824/en/
Findings show:
- 93 percent of Nuance clients are in the
top 50 percent of CareChex overall mortality ratings of U.S.
hospitals, and exceeded national benchmarks for mortality rating
performance.
- 36 percent of Nuance CDI clients are in
the top 10 percent of hospitals in analysis of CareChex overall
mortality rating performance
- Hospitals that deploy Nuance’s CDI
program see significant improvement in quality ratings post
implementation, including up to two times improvement on mortality
ratings, and up to seven times improvement on expected mortality
ratings.
“In the emerging value-based healthcare economy, payments and
reimbursement are inextricably linked to the quality of care that
is delivered, documented and measured,” explains Shane Wolverton,
senior vice president corporate development, Quantros. “Winners in
this new climate will be the organizations that accurately capture
and report performance on a multitude of quality measures and
performance indicators, and which are not sufficiently reconcilable
through the lens of coding metrics or case mix index (CMI)
alone.”
CareChex® is an innovative medical quality rating system
designed to assist providers and purchasers in evaluating the
quality of inpatient care using a patent pending quality scoring
system which integrates the most reliable quality indicators
available in the industry into a single, multi-dimensional,
composite score and rating. Relying on both public and proprietary
measures of performance, CareChex® compares the quality of hospital
and physician care to national and state standards using a variety
of clinical indicators to assign a proprietary Composite Quality
Score and Rating. Unlike other rating systems, CareChex® provides a
multidimensional, integrated analysis of medical quality and
incorporates seven peer-reviewed methodologies which address key
components of the quality of inpatient care.
“The implementation of our clinically-focused CDI program
combined with CareChex® analytics affords hospitals an even
stronger and more realistic severity-adjusted view of the quality
of care delivered to patients in value-based care models,” said
Anthony Oliva, vice president and chief medical officer, Nuance.
“Hospitals need data to know where to focus their efforts -- where
they need quality improvement and how much of that is a physician
documentation problem. One impactful way to remove the noise and
pinpoint where to focus is through a CDI program that is clinically
focused.”
More information about the CareChex® Hospital Quality Ratings is
available at http://www.carechex.com. For more information on
Nuance CDI solutions, visit Nuance booth #421 at The Healthcare
Financial Management Association (HFMA) National Institute, Las
Vegas June 26-29, 2016, Las Vegas, Nevada.
About Quantros, Inc.
Quantros is a leading provider of software and services to
advance healthcare quality and safety performance. Our Software-as
a-Service (SaaS)-based applications help thousands of hospitals,
retail pharmacies and some of the nation’s largest health systems
to capture actionable intelligence they can use to improve
outcomes, reduce risks and to reinforce their commitments to
delivering safer, higher-quality value-based care. For more
information, visit http://www.quantros.com or follow us on Twitter
@Quantros.
About Nuance Communications, Inc.
Nuance Communications, Inc. (NASDAQ: NUAN) is a leading provider
of voice and language solutions for businesses and consumers around
the world. Its technologies, applications and services make the
user experience more compelling by transforming the way people
interact with devices and systems. Every day, millions of users and
thousands of businesses experience Nuance’s proven applications.
For more information, please
visit www.nuance.com/healthcare.Connect with Nuance on social
media through the healthcare blog, What’s next, as well
as LinkedIn, and Twitter.
Nuance and the Nuance logo are trademarks or registered
trademarks of Nuance Communications, Inc. or its affiliates in the
United States and/or other countries. All other company names or
product names may be the trademarks of their respective owners.
The statements in this press release relating to future plans,
events or services, are forward-looking statements which are
subject to specific risks and uncertainties. There are a number of
factors which could cause actual events or results to differ
materially from those indicated in such forward looking statements,
including fluctuations in demand for the Nuance products, and the
continued development of Nuance products. The reader is warned not
to rely on these forward-looking statements without reservation,
since these are simply reflections of the current situation. Nuance
disclaims any obligation to update any forward-looking statements
as a result of developments occurring after the date of this
document.
View source
version on businesswire.com: http://www.businesswire.com/news/home/20160627005824/en/
Media:QuantrosNathan Molinari, 201-641-1911 x
22nmolinari@cpronline.comorNuance CommunicationsAnn Joyal,
781.565-4155ann.joyal@nuance.com
Nuance Communications (NASDAQ:NUAN)
Historical Stock Chart
From Aug 2024 to Sep 2024
Nuance Communications (NASDAQ:NUAN)
Historical Stock Chart
From Sep 2023 to Sep 2024